Nu Skin Enterprises, Inc. (NUS): Price and Financial Metrics


Nu Skin Enterprises, Inc. (NUS): $41.07

-0.35 (-0.85%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NUS POWR Grades


  • Value is the dimension where NUS ranks best; there it ranks ahead of 99.34% of US stocks.
  • The strongest trend for NUS is in Quality, which has been heading down over the past 52 weeks.
  • NUS ranks lowest in Sentiment; there it ranks in the 8th percentile.

NUS Stock Summary

  • Nu Skin Enterprises Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 84.77% of US listed stocks.
  • Of note is the ratio of Nu Skin Enterprises Inc's sales and general administrative expense to its total operating expenses; 86.36% of US stocks have a lower such ratio.
  • With a price/sales ratio of 0.73, Nu Skin Enterprises Inc has a higher such ratio than merely 15.14% of stocks in our set.
  • Stocks that are quantitatively similar to NUS, based on their financial statements, market capitalization, and price volatility, are GNE, MOV, LL, HZO, and MIXT.
  • NUS's SEC filings can be seen here. And to visit Nu Skin Enterprises Inc's official web site, go to www.nuskin.com.

NUS Valuation Summary

  • In comparison to the median Consumer Defensive stock, NUS's price/sales ratio is 66.67% lower, now standing at 0.9.
  • NUS's price/sales ratio has moved up 0.2 over the prior 243 months.
  • NUS's price/sales ratio has moved up 0.2 over the prior 243 months.

Below are key valuation metrics over time for NUS.

Stock Date P/S P/B P/E EV/EBIT
NUS 2021-09-03 0.9 2.8 10.7 8.7
NUS 2021-09-02 0.9 2.7 10.7 8.7
NUS 2021-09-01 0.9 2.8 10.8 8.8
NUS 2021-08-31 0.9 2.8 10.7 8.7
NUS 2021-08-30 0.9 2.8 10.7 8.7
NUS 2021-08-27 0.9 2.8 11.0 8.9

NUS Growth Metrics

  • Its 2 year net cashflow from operations growth rate is now at -8.91%.
  • Its 5 year net income to common stockholders growth rate is now at 12.95%.
  • Its 3 year revenue growth rate is now at 23.48%.
Over the past 49 months, NUS's revenue has gone up $647,930,000.

The table below shows NUS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 2,832.621 214.919 236.542
2021-03-31 2,740.932 291.258 219.055
2020-12-31 2,581.934 379.141 191.355
2020-09-30 2,417.1 334.351 158
2020-06-30 2,303.687 269.535 145.783
2020-03-31 2,314.821 255.144 150.281

NUS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NUS has a Quality Grade of A, ranking ahead of 96.1% of graded US stocks.
  • NUS's asset turnover comes in at 1.458 -- ranking 53rd of 105 Wholesale stocks.
  • KAMN, WSO, and HSIC are the stocks whose asset turnover ratios are most correlated with NUS.

The table below shows NUS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.458 0.746 0.254
2021-03-31 1.458 0.744 0.243
2020-12-31 1.412 0.745 0.216
2020-09-30 1.357 0.750 0.180
2020-06-30 1.308 0.757 0.170
2020-03-31 1.315 0.758 0.178

NUS Price Target

For more insight on analysts targets of NUS, see our NUS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $65.20 Average Broker Recommendation 1.7 (Moderate Buy)

NUS Stock Price Chart Interactive Chart >

Price chart for NUS

NUS Price/Volume Stats

Current price $41.07 52-week high $63.85
Prev. close $41.42 52-week low $39.40
Day low $40.94 Volume 316,982
Day high $41.57 Avg. volume 490,932
50-day MA $45.21 Dividend yield 3.7%
200-day MA $52.86 Market Cap 2.06B

Nu Skin Enterprises, Inc. (NUS) Company Bio


Nu Skin Enterprises develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex brands worldwide. The company was founded in 1984 and is based in Provo, Utah.


NUS Latest News Stream


Event/Time News Detail
Loading, please wait...

NUS Latest Social Stream


Loading social stream, please wait...

View Full NUS Social Stream

Latest NUS News From Around the Web

Below are the latest news stories about Nu Skin Enterprises Inc that investors may wish to consider to help them evaluate NUS as an investment opportunity.

New Strong Sell Stocks for October 18th

CNFR, RACE, GGG, NUS, and LRN have been added to the Zacks Rank #5 (Strong Sell) List on October 18, 2021.

Yahoo | October 18, 2021

Rhyz Analytical Labs Launches Analytical Testing Services for Beauty and Wellness Companies

Rhyz Analytical Labs today announced the availability of its testing services for beauty and wellness companies to assess product safety and effectiveness through trusted, timely and accurate results. Rhyz Analytical Labs combines the knowledge of a team of experienced scientists across multiple disciplines with the latest technology and equipment to quickly and thoroughly address any testing requirements for foods, dietary supplements and cosmetic products.

Yahoo | October 13, 2021

Why The 22% Return On Capital At Nu Skin Enterprises (NYSE:NUS) Should Have Your Attention

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

Yahoo | October 13, 2021

Nu Skin's (NUS) Solid Innovations Aid, Pandemic-Led Hurdles Hurt

Nu Skin (NUS) is benefiting from effective product launches. However, the company is battling challenges stemming from the spread of the delta variant across several markets.

Yahoo | October 13, 2021

Infant Dietary Supplements Market SWOT Analysis till 2027 Players are Amway, Abbott, Arkopharma, Bayer AG, Glanbia plc, Pfizer Inc., ADM, Carlyle Investment Management L.L.C., Nu Skin Enterprises, GlaxoSmithKline Consumer Healthcare

Infant dietary supplements market is expected to grow at a rate of 14.0% in the forecast period 2020 to 2027. Increasing health awareness among the people will act as a factor for the infant dietary supplements market in the forecast

OpenPR | October 11, 2021

Read More 'NUS' Stories Here

NUS Price Returns

1-mo 0.32%
3-mo -22.00%
6-mo -22.91%
1-year -19.54%
3-year -35.35%
5-year -24.90%
YTD -23.20%
2020 38.67%
2019 -30.98%
2018 -8.32%
2017 46.55%
2016 30.47%

NUS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full NUS Dividend History

Continue Researching NUS

Here are a few links from around the web to help you further your research on Nu Skin Enterprises Inc's stock as an investment opportunity:

Nu Skin Enterprises Inc (NUS) Stock Price | Nasdaq
Nu Skin Enterprises Inc (NUS) Stock Quote, History and News - Yahoo Finance
Nu Skin Enterprises Inc (NUS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.2136 seconds.